A Novel Prognostic Factor TIPE2 in Bladder Cancer.

Area of Science:

• Oncology
• Molecular Biology
• Urothelial Carcinomas

Background:

• Tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 (TIPE2/TNFAIP8L2) is a protein implicated in cellular regulation.
• Its role in bladder cancer progression and patient prognosis requires further elucidation.

Purpose of the Study:

• To investigate the expression patterns of TIPE2 in bladder cancer tissues.
• To determine the correlation between TIPE2 expression and clinicopathological features.
• To evaluate the prognostic significance of TIPE2 in urothelial carcinoma of the bladder.

Main Methods:

• Immunohistochemical staining for TIPE2 was performed on 110 radical cystectomy specimens.
• TIPE2 expression levels were quantified by assessing immunoreactivity percentage and intensity, categorized into negative, low, and high expression.
• Statistical analyses, including correlation studies and multivariate Cox regression, were employed.

Main Results:

• TIPE2 was expressed in the nucleus and cytoplasm of bladder cancer cells, with high expression observed in 54.5% of cases.
• TIPE2 expression showed a negative correlation with lymph node metastasis (p=0.004) and disease progression (p=0.021).
• High TIPE2 expression was associated with significantly better progression-free survival (p=0.027) and identified as a protective factor in multivariate analysis (p=0.031).

Conclusions:

• TIPE2 expression is a significant independent prognostic factor for progression-free survival in bladder urothelial carcinoma.
• TIPE2 may serve as a novel biomarker for predicting disease progression and prognosis in bladder cancer patients.
• Further research into TIPE2's functional role in bladder cancer pathogenesis is warranted.